Israel Sees 5,565 New Breast Cancer Cases in 2023 Amid Falling Mortality Rates

In 2023, Israel recorded 5,565 new cases of breast cancer, maintaining its status as the most common malignancy among women. Despite a relatively high incidence rate, the country demonstrates significantly lower mortality rates compared to international benchmarks. Data from the National Cancer Registry, released ahead of Breast Cancer Awareness Month, indicate that 92% of Jewish and other women diagnosed with breast cancer survived for at least five years, compared to 87% of Arab women.

Of the 5,565 diagnoses, approximately 87% were invasive breast cancer, meaning the tumor had spread beyond its origin. The remaining 707 cases were localized tumors. While breast cancer accounts for about one-third of new cancer cases in women, recent trends show a decline in the risk of invasive breast cancer among Jewish and other women by an average of 1.6% annually since 2013. For Arab women, incidence rates have stabilized since 2015.

Israel ranks 33rd globally in breast cancer incidence but 125th in mortality, a disparity attributed by the Ministry of Health to high survival rates and advanced diagnostic and treatment capabilities. An increasing number of tumors are being detected at earlier stages, while the proportion of cases diagnosed after metastasis has decreased.

In 2023, 999 women died from breast cancer in Israel, representing about 18% of all cancer deaths among women. Significant decreases in mortality rates have been observed among Jewish and other women since 1996, while rates for Arab women have remained stable, highlighting population disparities.

Early detection remains crucial. The national program recommends mammograms every two years for women aged 50-74 at average risk, and annually for those 40 and older with increased risk. Experts emphasize the importance of regular screenings and prompt medical evaluation for any suspicious changes, such as a new lump, skin dimpling, or nipple discharge.